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Coronavirus infectious bronchitis virus (IBV) encodes a trypsin-like proteinase (3C-like proteinase) by ORF 1a, which has
been demonstrated to play a pivotal role in proteolytic processing of gene 1-encoded polyproteins. In our previous studies,
the proteinase was identified as a 33-kDa protein in IBV-infected cells, and its catalytic center was shown to consist of H2820
and C2922 residues. It is released from the 1a and 1a/1b polyproteins by autoprocessing at two Q–S dipeptide bonds
(Q2779–S2780 and Q3086–S3087). In this report, further characterization of the two cleavage sites demonstrates that the N-terminal
Q2779–S2780 site is tolerant to mutations at the P1 position. Deletion of the C-terminal region of the proteinase shows that a
significant amount of the enzymatic activity is maintained upon deletion of up to 67 amino acids, suggesting that the extreme
C-terminal region may be dispensable for the proteolytic activity of the proteinase. Analysis of the autoprocessing kinetics
in vitro reveals that proteolysis at the Q2779–S2780 site is the first cleavage event mediated by this proteinase. This is followed
by cleavage at the Q3086–S3087 site. The occurrence of both cleavage events in intact cells is potentially rapid and efficient, as
no intermediate cleavage products covering the proteinase were detected in either IBV-infected or transfected cells.
Immunofluorescence microscopy and subcellular fractionation studies further show differential subcellular localization of the
proteinase in IBV-infected cells and in cells expressing the 3C-like proteinase alone, indicating that additional roles in viral
replication might be played by this protein. Finally, a Q–A (Q3379–A3380) dipeptide bond encoded by nucleotides 10,663 to 10,668
was demonstrated to be a cleavage site of the proteinase. © 2000 Academic PressINTRODUCTION
The avian coronavirus infectious bronchitis virus (IBV)
is now categorized under a new order, Nidovirales (Ca-
vanagh, 1997; de Vries et al., 1997). Its 27.6-kb genome-
length mRNA, mRNA1, is composed of two large over-
lapping ORFs (1a and 1b) at the 59-unique region and
encodes a fusion polyprotein of 741 kDa by a unique
frameshifting mechanism (Boursnell et al., 1987; Brierly
et al., 1987, 1989). Proteolytic processing of the 441-kDa
1a and 741-kDa 1a/1b fusion polyproteins to smaller
mature products is mediated by viral proteinases. Three
proteinase domains, namely, two overlapping papain-like
proteinase domains and a picornavirus 3C-like protein-
ase domain (3C-like proteinase) (Fig. 1a), have been
predicted to be encoded by ORF 1a (Boursnell et al.,
1987; Gorbalenya et al., 1989; Lee et al., 1991).
In recent years, progress has been made in the iden-
tification and characterization of the proteinase activities
as well as their cleavage products. The first papain-like
proteinase domain is involved in proteolytic cleavage of
the N-terminal region of the 1a and 1a/1ab polyproteins
to release an 87-kDa protein and a 195-kDa protein and
the N-terminus of a 41-kDa product in IBV-infected cells1 To whom correspondence and reprint requests should be ad-
ressed. E-mail: liudx@ima.org.sg.
27(Liu et al., 1995; Lim and Liu, 1998; Lim et al., 2000).
Similar enzymatic activities were also reported for the
first papain-like proteinase domain of human and murine
coronaviruses. In mouse hepatitis virus (MHV), two N-
terminal cleavage products (p28 and p65) have been
reported (Hughes et al., 1995; Bonilla et al., 1997; Baker
et al., 1989, 1993; Dong and Baker, 1994; Gao et al., 1996;
Schiller et al., 1998). The same domain of human coro-
navirus (HCV) processes the two polyproteins to release
p9 (Herold et al., 1998).
Important roles in processing of the 1a and 1a/1b
polyproteins are also played by the 3C-like proteinase
domain. Characterization of the proteinase activities has
shown that it cleaves the bulk of the polyproteins at
conserved Q–S (G and N) dipeptide bonds, resulting in
the release of more than 10 mature products (Liu et al.,
1994, 1995, 1997, 1998; Ng and Liu, 1998; Tibbles et al.,
1999; Ziebuhr and Siddell, 1999; Grotzinger et al., 1996;
Heusipp et al., 1997a, b; Lu et al., 1995, 1998; Schiller et
al., 1998). The proteinase was identified as a 27-kDa
protein for MHV (Lu et al., 1996) and a 34-kDa protein for
HCV (Ziebuhr et al., 1995). The catalytic center of the
proteinase consists of a His residue and a Cys residue
(Liu and Brown, 1995; Lu et al., 1995; Seybert et al., 1997;
Ziebuhr et al., 1995, 1997).The 3C-like proteinase domain is flanked by hydropho-
bic regions in the coronaviral genomes. In vitro studies in
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28 NG AND LIUMHV have shown that its enzymatic activity can be
greatly enhanced by the addition of canine pancreatic
microsomal membranes to the translation reaction mix-
ture (Pinon et al., 1997; Schiller et al., 1998). The proteo-
lytic activity of the proteinase could be inhibited by a
variety of cysteine and serine inhibitors and was elimi-
nated by the cysteine proteinase inhibitor E64d (Lu et al.,
1996; Pinon et al., 1997; Seybert et al., 1997). More re-
cently, immunofluorescence studies using region-spe-
cific antisera against several 1a and 1a/1b cleavage
products including the 3C-like proteinase have sug-
gested that the proteinase may be associated with the
viral RNA replication–transcription machinery (Schiller et
al., 1998; Ziebuhr and Siddell, 1999; Shi et al., 1999;
Denison et al., 1999; van der Meer et al., 1999).
In a previous study, we identified the IBV 3C-like pro-
teinase as a 33-kDa protein in IBV-infected Vero cells
(Lim et al., 2000). The proteinase was shown to be
self-cleaved from the polyproteins at the two previously
predicted Q–S dipeptide bonds (Q2779–S2780 and Q3086–
3087) in an in vitro processing assay (Tibbles et al., 1996).
The in vitro proteolytic activity was shown to be strictly
dependent on the addition of canine microsomal mem-
branes (Tibbles et al., 1996). Here, we show, by deletion
and mutational analyses, that the N-terminal cleavage
site of the 3C-like proteinase is tolerant to mutations and
the extreme C-terminal region may be dispensable for
the enzymatic activity. The proteinase could be self-
cleaved to the 33-kDa mature form in vitro in rabbit
reticulocyte lysate without the addition of canine micro-
somal membranes. Immunofluorescence staining and
cellular fractionation studies demonstrated that the pro-
teinase is associated mainly with the membrane fraction
in virus-infected cells. However, a free distribution pat-
tern was observed when the proteinase was overex-
pressed in intact cells. Finally, instead of the previously
predicted Q3365–G3366 dipeptide bond, the Q3379–A3380
dipeptide bond was identified as a cleavage site of the
proteinase.
RESULTS
Tolerance of the N-terminal cleavage site (Q2779–S2780)
of the 3C-like proteinase to mutations
The previously predicted Q2779–S2780 dipeptide bond
as shown to be the N-terminal cleavage site of the
FIG. 1. (a) Diagram of ORF1a, illustrating the two overlapping papain
he Q2779–S2780, Q3086–S3087, Q3379–A3380, and Q3462–S3463 scissile bonds
indicated. Also shown are the IBV sequence recognized by anti-3C, the
present in pIBV9, pIBV9D1Q2779–E, and pIBV9D1Q2779–K. The viral prod
products encoded by some plasmids are illustrated. The molecular
SDS–PAGE. The Q2779–S2780, Q3086–S3087, Q3379–A3380, and Q3462–S3463 resid
0,912–10,917, respectively. (b) Mutational analysis of the Q2779–S2780 dip
tively, were transiently expressed in Cos-7 cells using the vaccinia-T7 eere prepared, and polypeptides were immunoprecipitated with anti-3C. Gel
olyacrylamide gel and polypeptides were detected by fluorography.C-like proteinase in an in vitro processing assay
Tibbles et al., 1996). Substitution mutagenesis was car-
ied out to investigate the effects of mutations on the
elf-cleavage efficiency of the proteinase at this position.
he Q2779–S2780 dipeptide bond was first mutated to E2779–
2780, giving rise to pIBV9D1Q2779–E (Fig. 1a). Expression
of pIBV9D1Q2779–E led to the detection of three protein
species (Fig. 1b, lane 2). In addition to the 33-kDa pro-
tein, two products of approximately 43 and 48 kDa, re-
spectively, were also detected (Fig. 1b, lane 2). The
43-kDa protein may represent a fusion product contain-
ing the 33-kDa protein and the product encoded by
nucleotides 8693 to 8865, and the 48-kDa protein may
represent the full-length product encoded by this con-
struct (Fig. 1a). As a significant amount of the 33-kDa
protein was detected from the expression of this con-
struct (Fig. 1b, lane 2), this result indicates that an E–S
dipeptide could be used efficiently by the 3C-like pro-
teinase at this position. Substitution of the Q2779 residue
ith a K was then carried out, giving rise to
IBV9D1Q2779–K (Fig. 1a). Expression of this construct
resulted in more efficient detection of the 43- and 48-kDa
products (Fig. 1b, lane 3). However, a trace amount of the
33-kDa protein was still detected (Fig. 1b, lane 3). These
results suggest that cleavage at the Q2779–S2780 dipeptide
bond may be tolerant to mutations and the Q to E sub-
stitution is better tolerated than the Q–K substitution.
Mutation and deletion analyses of the C-terminal
region of the 3C-like proteinase
Mutation of the C-terminal cleavage site (Q3086–S3087
dipeptide bond) of the 3C-like proteinase to E3086–S3087
was subsequently made, giving rise to pIBV9Q3086–E (Fig.
2a). Expression of pIBV9Q3086–E led to the detection of a
novel product with an apparent molecular mass of ap-
proximately 35 kDa (Fig. 2b, lane 2). No 33-kDa protein
was observed (Fig. 2b, lane 2). This was unexpected, as
no further cleavage site was predicted to be located
30–60 bp downstream of the Q3086–S3087 dipeptide bond.
o investigate the possibility that the C-terminus of the
5-kDa protein may be derived from a novel cleavage
ite located 10 to 20 amino acid residues downstream of
he Q3086 residue, two deletion plasmids, pIBV9Q3086–ED1
nd pIBV9Q3086–ED2, were constructed. As can be seen
in Fig. 2a, the IBV sequence present in pIBV9Q3086–ED1
oteinase domains (PLPDs) and the 3C-like proteinase domain (3CLP).
al products generated from cleavage by the 3C-like proteinase are
es of hydrophobic residues encoded by ORF1a and the IBV sequences
enerated from cleavage by the 3C-like proteinase and the full-length
of these products were estimated according to their migration on
e encoded by nucleotides 8863–8868, 9784–9789, 10,663–10,668, and
bond. Plasmids pIBV9, pIBV9D1Q2779–E, and pIBV9D1Q2779–K, respec-
ion system. Cells were labeled with [35S]methionine–cysteine, lysates-like pr
and vir
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on an SDS–12.5% polyacrylamide gel and polypeptides were de-
tected by fluorography.
30 NG AND LIUwas terminated at nucleotide position 9911. Expression
of this construct, once again, led to the detection of the
35-kDa protein (Fig. 2b, lane 3). Meanwhile, a novel
product migrating more slowly than the 35-kDa protein
was also detected (Fig. 2b, lane 3). Its apparent molec-
ular mass of 39 kDa suggests that it is a fusion product
containing the 35-kDa protein and the product encoded
by nucleotides up to 9911. pIBV9Q3086–ED2 was con-
tructed by introducing a UGA termination codon imme-
iately downstream of the Q3086 residue (Fig. 2a). Inter-
estingly, expression of this plasmid led to the detection of
a single protein species comigrating with the 35-kDa
protein processed from pIBV9Q3086–ED1 (Fig. 2b, lane 4),
suggesting that the E3086 residue is actually the C-termi-
us of the 35-kDa protein expressed from pIBV9Q3086–E
and pIBV9Q3086–ED1. These results demonstrate that mu-
tation of the Q3086 residue to an E only marginally reduces
he cleavage efficiency occurring at the Q3086–S3087 dipep-
tide bond, but alters the mobility of the 33-kDa protein on
SDS–PAGE.
To investigate the possibility that the C-terminal region
of the 3C-like proteinase may contain sequences nones-
sential for the catalytic activity of the proteinase, five
deletion constructs, pIBV9D19, pIBV9D20, pIBV9D21,
pIBV9D22, and pIBV9D23, were made and expressed in
intact cells. These constructs encode proteins with de-
letions of 3, 7, 33, 67, and 135 amino acid residues,
respectively, from the C-terminus of the 3C-like protein-
ase. Expression of pIBV9D19 and pIBV9D20 showed that
almost full enzymatic activity was maintained upon the
deletions. As can be seen, a 35-kDa product represent-
ing the C-terminally truncated form of the 3C-like protein-
ase was detected in both cases (Fig. 2b, lanes 6 and 7).
No full-length product was observed from the expression
of pIBV9D19 (Fig. 2b, lane 6), but a trace amount of the
full-length product was detected from the expression of
pIBV9D20 (Fig. 2b, lane 7). Progressively less enzymatic
activity was observed when pIBV9D21 and pIBV9D22
were expressed. In each case, two products represent-
ing the full-length proteins and the C-terminally truncated
3C-like proteinase were detected (Fig. 2b, lanes 8 and 9).
Expression of pIBV9D23 showed the detection of the
full-length product only (Fig. 2b, lane 10), indicating that
the catalytic activity was abolished by this deletion.
These results suggest that the extreme C-terminal region
is not essential for the catalytic activity of the 3C-like
proteinase.
Characterization of the in vitro enzymatic activity of
the 3C-like proteinase
Studies on the 3C-like proteinase of human and mu-
rine coronaviruses have demonstrated that microsomal
membranes are not strictly required for the in vitro cleav-FIG. 2. (a) Diagram showing the IBV sequences present in
pIBV9Q3086–E, pIBV9Q3086–ED1, pIBV9Q3086–ED2, pIBV9D19, pIBV9D20,
IBV9D21, pIBV9D22, and pIBV9D23. The viral products generated
rom cleavage by the 3C-like proteinase and the full-length products
ncoded by some plasmids are illustrated. The molecular masses of
hese products were estimated according to their migration on
DS–PAGE. The Q3086 residue is encoded by nucleotides 9784–9786.
(b) Mutational and deletion analyses of the Q3086–S3087 dipeptide
bond and the C-terminal region of the 3C-like proteinase. Plasmids
pIBV9, pIBV9Q3086–E, pIBV9Q3086–ED1, pIBV9Q3086–ED2, pIBV9D19,
IBV9D20, pIBV9D21, pIBV9D22, and pIBV9D23, respectively, were
ransiently expressed in Cos-7 cells using the vaccinia-T7 system.
he cells were labeled with [35S]methionine–cysteine, lysates were
repared, and the labeled polypeptides were immunoprecipitated
ith anti-3C. Gel electrophoresis of the polypeptides was performedage activity but addition of the membranes can greatly
enhance the autoprocessing activity of the proteinase
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313C-LIKE PROTEINASE OF AVIAN CORONAVIRUS IBV(Lu et al., 1996; Pinon et al., 1997; Schiller et al., 1998;
Heusipp et al., 1997a). However, the microsomal mem-
branes were shown to be indispensable for the in vitro
activity of the IBV 3C-like proteinase (Tibbles et al., 1996).
To clarify this discrepancy, plasmid pIBV1a7D1, which
covers nucleotides 7999 to 9786 and contains the up-
stream hydrophobic region (M1), was expressed in vitro
in a rabbit reticulocyte lysate system and pulse–chased
for up to 8 h. Aliquots were removed at the indicated time
and the reactions were stopped by the addition of RNase
A. The 33-kDa protein was detected after incubation for
1 h and its expression steadily increased toward the end
of the time course (Fig. 3). The expression of the full-
length 54-kDa protein meanwhile decreased rapidly over
time (Fig. 3). The addition of microsomal membranes did
not significantly increase the autoprocessing rate of the
33-kDa protein (data not shown). These results demon-
strate that autoprocessing of the IBV 3C-like proteinase
could occur in vitro in reticulocyte lysate in the absence
of the membranes.
In vitro autoprocessing kinetics of the 3C-like
proteinase
The in vitro processing system was then used to study
the autoprocessing kinetics of the IBV 3C-like protein-
ase. Plasmids pIBV9Q3086–ED1 and its parental construct
IBV1a9D17 (Fig. 4a) were expressed in reticulocyte ly-
ate and pulse–chased for up to 2 h. The full-length
8-kDa product was observed from the expression of
oth constructs after chase for 10 min, and its expression
radually decreased toward the end of the time course
Fig. 4b). The appearance of a 39-kDa product, repre-
enting the fusion protein containing the 3C-like protein-
se and the product encoded by nucleotides 9787 to
910, was observed after chase for 20 min (Fig. 4b). It
eaks after chase for 60 min and then starts to decline
FIG. 3. Time course analysis of the autoprocessing of the 3C-like
proteinase expressed from pIBV1a7D1 in rabbit reticulocyte lysates. A
10-fold excess of unlabeled methionine was added to the in vitro
translation reaction after incubation at 30°C for 10 min. Aliquots were
subsequently taken from the reaction after incubation for 0, 1, 2, 3, 4, 5,
6, 7, and 8 h. The [35S]methionine-labeled products were separated on
an SDS–12.5% polyacrylamide gel and detected by fluorography.Fig. 4b). The 33-kDa protein was first seen from the
xpression of pIBV1a9D17 after chase for 30 min andradually increased toward the end of the time course
Fig. 4b). The 35-kDa mutant 3C-like proteinase ex-
ressed from pIBV9Q3086–ED1 appeared slightly later
than the wild-type proteinase. It was first seen after
chase for 40 min (Fig. 4b, lane 14).
Differential subcellular localization of the 3C-like
proteinase in virus-infected and transfected cells
Determination of the subcellular localization of ORF
1a-encoded viral products from the Nidovirales family,
namely, MHV-A59, MHV-JHM, HCV-229E, and equine ar-
teritis virus (EAV), was the subject of several recent
reports (Shi et al., 1999; Schiller et al., 1998; Ziebuhr and
Siddell, 1999; van der Meer et al., 1998, 1999). It was
interesting to note that immunofluorescence staining of
viral infected cells using anti-3C antiserum showed dis-
tinct punctuate perinuclear staining patterns (Schiller et
al., 1998; Shi et al., 1999; Denison et al., 1999; van der
eer et al., 1999), suggesting that the proteinase may be
ssociated with intracellular membranes. To study the
ubcellular localization patterns of the IBV 3C-like pro-
einase, the proteinase was tagged to an 11-amino-acid
7 tag (MASMTGGQQMG) derived from the major capsid
rotein of bacteriophage T7, and a highly specific anti-T7
onoclonal antibody (Novagen) was used to stain cells
verexpressing the fusion protein. This procedure is
sed to avoid the high background of the anti-3C poly-
lonal antiserum when it was used in indirect immuno-
luorescence assays. As can be seen in Figs. 5A and 5B,
taining of Vero cells expressing the T7 tagged 3C-like
roteinase with anti-T7 antibody showed a diffuse cyto-
lasmic staining profile. Indirect immunofluorescence
taining of IBV-infected Vero cells with anti-3C antiserum
howed a distinct perinuclear punctate pattern at 13 h
ostinfection (Fig. 5D), although high background was
lso observed for the mock-infected cells (Fig. 5C). This
istribution pattern is similar to those reported for other
oronaviruses and arteriviruses (Schiller et al., 1998; Shi
t al., 1999; van der Meer et al., 1998). These results
suggest that the IBV 3C-like proteinase may exhibit dif-
ferential subcellular distribution patterns in virus-in-
fected cells and in transfected cells. When it was ex-
pressed individually, a diffuse distribution profile was
observed. However, the proteinase was shown to be
associated with intracellular membranous structures in
virus-infected cells.
Subcellular fractionation of pIBV3C-transfected and
IBV-infected cells was then carried out to investigate this
possibility further. Two fractions, namely, the membrane
and cytosol fractions, were collected and subjected to
immunoprecipitation with anti-3C antiserum. Figure 6a
shows that approximately equal amounts of the 33-kDa
proteinase were detected from both fractions (Fig. 6a,
lanes 1 and 3). Quantification by densitometry confirmed
that the membrane and cytosol fractions contain 50.19
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32 NG AND LIUand 49.66%, respectively, of the 3C-like proteinase. In a
control experiment, the IBV membrane protein was ex-
clusively detected in the membrane fraction (Fig. 6a, lane
6). Similarly, IBV-infected Vero cells were fractionated
into the membrane and cytosol fractions. Immunoprecipi-
tation and quantification assays showed that 76% of the
33-kDa proteinase was detected in the membrane frac-
tion (Fig. 6b, lane 3), while only 24% of the protein was
detected in the cytosol (Fig. 6b, lane 5). Once again, the
IBV membrane protein was detected only in the mem-
brane fraction (Fig. 6b, lane 4).
Identification of the Q3379–A3380 dipeptide bond as a
cleavage site of the 3C-like proteinase
The Q3365–G3366 dipeptide bond encoded by nucleo-
ides 10,621 to 10,626 was previously predicted to be a
leavage site of the 3C-like proteinase (Gorbalenya et al.,
3379 3380
FIG. 4. (a) Diagram showing the IBV sequences present in pIBV9D17 a
roteinase and the full-length products encoded by the two plasmid
ccording to their migration on SDS–PAGE. The Q3086 residue is enc
synthesized in rabbit reticulocyte lysates from pIBV9D17 and pIBV9Q3
ranslation reaction mixtures after incubation at 30°C for 10 min. Aliquo
0, 30, 40, 60, 90, and 120 min. The radiolabeled translation produc
luorography.989). In a separate report, the Q –A dipeptide
bond, which is located 14 amino acids downstream ofthe Q3365–G3366 dipeptide bond and is conserved in all
four sequenced coronaviruses (Lu et al., 1998), was also
predicted to be a cleavage site of the 3C-like proteinase
(Lee et al., 1991). The equivalent Q–A dipeptide bond of
uman coronavirus was actually identified as a genuine
leavage site (Ziebuhr and Siddell, 1999). In an in vitro
tudy, Tibbles et al. (1999) recently reported that the
3365–G3366 dipeptide bond may be not used by the IBV
3C-like proteinase. However, the cleavability of the Q3379–
A3380 dipeptide bond was not mentioned in their report
(Tibbles et al., 1999). To further study whether either site
is used by the IBV 3C-like proteinase, deletion and mu-
tational analyses were carried out. As antiserum against
this specific region was not available, the two down-
stream cleavage sites were disabled by site-directed
mutagenesis, and anti-24 and antiserum V47 were used
to immunoprecipitate the potential cleavage products
V9Q3086–ED1. The viral products generated from cleavage by the 3C-like
llustrated. The molecular masses of these products were estimated
y nucleotides 9784–9786. (b) Time course analysis of polypeptides
. A 10-fold excess of unlabeled methionine was added to the in vitro
subsequently taken from the reaction mixtures after incubation for 10,
e separated on an SDS–12.5% polyacrylamide gel and detected bynd pIB
s are i
oded b
086–ED1
ts were(Ng and Liu, 1998) (Fig. 7a). Expression of pIBV1a16
resulted in the detection of the 33-kDa protein and a
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333C-LIKE PROTEINASE OF AVIAN CORONAVIRUS IBVprotein of approximately 46 kDa (Fig. 7b, lanes 1 and 3).
The 46-kDa protein may represent the C-terminal cleav-
age product with its N-terminus derived from cleavage at
either the Q3365–G3366 or Q3379–A3380 dipeptide bond. Mu-
tation of the Q3365 residue to an E did not change the
expression pattern of the construct (Fig. 7b, lanes 2 and
4), indicating that the Q3365–G3366 dipeptide bond may be
not used. To confirm this possibility, the Q3365–G3366 dipep-
ide bond was deleted from pIBV1a16, giving rise to
IBV1a16D1 (Fig. 7a). As can be seen in Fig. 7b, expres-
ion of pIBV1a16D1 resulted in the detection of both the
3- and the 46-kDa proteins and a product of approxi-
ately 52 kDa (lanes 5, 6, and 7). The 52-kDa protein may
epresent an intermediate cleavage product containing
he 46-kDa protein and product encoded by the upstream
egion in this construct (Fig. 7a). As the 46-kDa cleavage
roduct was still detected from this deletion construct,
his result rules out the possibility that the Q3365–G3366
dipeptide bond could be used by the 3C-like proteinase.
Similar deletion and mutational studies were then car-
ried out to study whether the Q3379–A3380 dipeptide bond is
used by the proteinase to release the 46-kDa protein.
Mutation of the Q3379 to an E led to the detection of only
he 33- and 52-kDa products (Fig. 7b, lanes 8, 9, and 10).
he 46-kDa protein was not detected (Fig. 7b, lanes 8
nd 9), indicating that the Q3379 to E mutation blocks
leavage occurring at the Q3379–A3380 dipeptide bond. This
ossibility was further studied by construction of
IBV1a16D2, which contains a deletion of nucleotides
911 to 10,669 and thus excludes the Q3379–A3380 dipep-
FIG. 5. Subcellular localization of the 3C-like proteinase. (A) Immu-
nofluorescence staining of vTF7-infected Vero cells with anti-T7 mono-
clonal antibody (1:200). (B) Immunofluorescence staining of vTF7-in-
fected and pIBVT7-3C-transfected Vero cells with anti-T7 monoclonal
antibody (1:200) at 6 h posttransfection, showing cytoplasmic staining.
(C) Immunofluorescence staining of the mock-infected Vero cells with
anti-3C (1:20). (D) Immunofluorescence staining of IBV-infected Vero
cells with anti-3C (1:20) at 13 h postinfection, showing distinct punctate
perinuclear staining. All photos were taken with an epifluorescence
microscope (Olympus Ix70, Tokyo), 3400.tide bond (Fig. 7a). Expression of this construct resulted
in the detection of both the 33-kDa protein and a product
c
Pmigrating slightly more rapidly than the 52-kDa protein
(Fig. 7b, lanes 11, 12, and 13). Its apparent molecular
mass is approximately 51 kDa, which may represent the
deleted version of the 52-kDa protein. Once again, the
46-kDa protein was not observed (Fig. 7b, lanes 11 and
12). These results confirmed that the Q3379–A3380 dipeptide
bond is a scissile bond of the 3C-like proteinase. Taken
together with the previously identified Q3462–S3463 dipep-
tide bond (Ng and Liu, 1998), cleavage at this position
would result in the release of a mature product of ap-
proximately 9 kDa.
DISCUSSION
The IBV 3C-like proteinase plays a major role in pro-
cessing of the gene 1-encoded polyproteins to smaller
functional products associated with viral RNA replica-
tion. Previous studies using an in vitro processing assay
showed that this proteinase may be released from the 1a
polyprotein by self-cleavage at two Q–S dipeptide bonds
FIG. 6. (a) Subcellular fractionation of cells transiently expressing the
3C-like proteinase and IBV M protein, respectively. Cos-7 cells were
transfected with appropriate plasmids and labeled with [35S]methio-
nine–cysteine. The cells were broken by a Dounce homogenizer and
were fractionated into the membrane and cytosol fractions. Polypep-
tides in the two fractions were immunoprecipitated with anti-3C and
anti-M, respectively. Gel electrophoresis of the polypeptides was per-
formed on an SDS–12.5% polyacrylamide gel and polypeptides were
detected by fluorography. (b) Subcellular fractionation of IBV-infected
cells. Vero cells were infected with IBV, labeled with [35S]methionine–ysteine, and fractionated into the membrane and cytosol fractions.
olypeptides were immunoprecipitated with anti-3C and anti-M.
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353C-LIKE PROTEINASE OF AVIAN CORONAVIRUS IBV(Q2779–S2780 and Q3086–S3087), and the in vitro enzymatic
activity is strictly dependent on the addition of microso-
mal membranes (Tibbles et al., 1996). In this study, we
show that the IBV 3C-like proteinase is active in vitro
even in the absence of microsomal membranes and that
addition of the membranes only marginally increases the
cleavage efficiency. Time-course and pulse–chase ex-
periments further showed that efficient autoprocessing
of the 3C-like proteinase occurs when the IBV sequence
from nucleotide 8693 to 9911 was expressed in vitro (Fig.
4b). This is inconsistent with the results reported by
Tibbles et al. (1996), showing no autoprocessing of the
3C-like proteinase when the same region was expressed
in vitro even in the presence of microsomal membranes
(Tibbles et al., 1996). The reason for this discrepancy is
currently unclear. However, the in vitro enzymatic activi-
ties of the IBV 3C-like proteinase reported here resemble
the equivalent proteinase of human and murine corona-
viruses. For example, the 3C-like proteinases of both
human and murine coronaviruses are active when ex-
pressed in vitro (Heusipp et al., 1997a; Lu et al., 1995;
Schiller et al., 1998), and autoprocessing of the MHV
3C-like proteinase was slightly increased by the addition
of microsomal membranes when only the upstream hy-
drophobic region was presented (Pinon et al., 1997).
The mutagenesis studies presented here support the
conclusion that the Q2779–S2780 and Q3086–S3087 dipeptide
onds are the N- and C-terminal cleavage sites, respec-
ively, of the 3C-like proteinase. Interestingly, substantial
leavage was observed after mutation of either site to
–S, suggesting that the P1 position at these two sites
re more tolerant to mutagenesis. However, much less
olerance to alterations at the P1 position was observed
or the rest of the 11 cleavage sites identified so far (Liu
t al., 1997, 1998; Liu and Brown, 1995; Ng and Liu, 1998).
he reasons for this difference are uncertain, but it may
eflect the differing cleavage efficacy between the cis-
nd trans-enzymatic activities of the proteinase. The ki-
etic studies present here clearly indicate that cleavage
irst takes place at the Q2779–S2780 dipeptide bond, which
is followed by cleavage at the Q3086–S30870 dipeptide bond,
resulting in the release of the 3C-like proteinase. Cleav-
age at these two sites is therefore mediated by the cis
activity of the proteinase. This process is very rapid and
efficient, as no precursor containing the proteinase was
detected even when the region was overexpressed in
intact cells. Processing at other sites is thus likely me-
diated by the “free” 3C-like proteinase in trans. To argue
FIG. 7. (a) Diagram of pIBV1a16, pIBV1a16Q3365–E, pIBV1a16D1, pIBV
nd the substitution mutations that were introduced. The viral product
olecular masses of these products were estimated according to the
Q3462, and Q3672 residues are encoded by nucleotides 8863–8868, 9
espectively. (b) Mutation and deletion analyses of the Q3379–A3380 dipepexpressed in Cos-7 cells using the vaccinia-T7 system. Cells were labeled wit
ith anti-24 and anti-3C, respectively. Polypeptides were separated on an SDagainst this speculation, Pinon et al. (1999) have recently
reported that mutations of either the P1 or the P2 residue
of the N-terminal QS site abolished in vitro autoprocess-
ing of the MHV 3C-like proteinase.
Another interesting observation is that mutation of the
Q3086 residue to an E alters the mobility of the 33-kDa
proteinase on SDS–PAGE, yet almost full enzymatic ac-
tivity of the proteinase is maintained. Mutation of the
equivalent Q3267 residue of HCV-229E 3C-like proteinase
to an A exerts no effect on the proteinase activity, al-
though information on the mobility of this mutant on
SDS–PAGE was not available (Ziebuhr et al., 1997). De-
letion of up to 7 amino acids from the C-terminus of the
IBV 3C-like proteinase renders no significant effect on
the enzymatic activity of the proteinase. Progressive loss
of the activity was observed when further deletions were
made. Interestingly, significant enzymatic activity was
still maintained when the C-terminal 67 amino acid res-
idues were deleted. Furthermore, the three mutant forms
(the Q3086–E mutant and the two mutants with deletions of
3 and 7 amino acids) migrate on SDS–PAGE significantly
more slowly than the wild-type proteinase. These results
suggest that the extreme C-terminal region may be able
to fold into a unique structure independent of the cata-
lytic domain, which is located at the N-terminal half of the
protein. Cotranslational folding of a functionally active
proteinase domain may occur even before the whole
proteinase is synthesized. This argument would be sup-
ported by several recent studies on eukaryotic protein
folding. It was demonstrated that rapid and efficient fold-
ing of modular model proteins depends on sequential
folding of their domains during synthesis (Netzer and
Hartl, 1997; Nicola et al., 1999; Louis et al., 1999). Co-
translational folding of two proteinase domains with en-
zymatic activities was observed when the novel polypep-
tide chains were still bound to the ribosome (Nicola et
al., 1999; Louis et al., 1999). This is in contrast to the
protein folding in prokaryotic system, in which the folding
of a functional domain occurs posttranslationally (Netzer
and Hartl, 1997). This different folding mechanism may
explain the data reported by Ziebuhr et al. (1997), show-
ing that the HCV-229E 3C-like proteinase expressed in
bacteria was inactivated by deletion of the C-terminal 33
amino acid residues.
Immunofluorescence staining of coronavirus-infected
cells using anti-3C antibodies reveals distinct perinu-
clear, puctate staining patterns in several recent reports
(van der Meer et al., 1998, 1999; Schiller et al., 1998; Shi
Q3379–E, and pIBV1a16D2, showing the locations of the cleavage sites
rated from cleavage by the 3C-like proteinase are illustrated, and the
tion on SDS–PAGE. The Q2779–S2780, Q3086–S3087, Q3365–G3366, Q3379–A3380,
789, 10,621–10,626, 10,663–10,668, 10,912–10,914 and 11,542–11,544,
nd. Plasmids pIBV1a16D1, pIBV1a16D1Q3379–E, and pIBV1a16D2 were1a16D1
s gene
ir migra
784–9
tide boh [35S]methionine–cysteine and total lysates were immunoprecipitated
S–12.5% polyacrylamide gel and detected by fluorography.
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36 NG AND LIUet al., 1999). As rapid self-cleavage of the 3C-like pro-
teinase from the polyprotein precursors was reported for
these viruses, these staining patterns should be contrib-
uted mainly by the staining of the mature 3C-like protein-
ase. In this report, we present evidence showing that the
IBV 3C-like protein displays a free distribution pattern
when it was expressed in intact cells alone. However, in
IBV-infected cells, the proteinase is associated mainly
with the intracellular membranes. Two possibilities may
be responsible for these different distribution patterns.
First, the 3C-like proteinase may be sequestered to cel-
lular membranous compartments by interacting with
other viral or cellular proteins. Recently, we showed that
anti-3C antiserum could immunoprecipitate a protein
band of about 170 kDa in IBV-infected cells (Lim et al.,
2000). The same protein species could also be detected
by several other IBV region-specific antisera (Lim et al.,
2000). As the 170-kDa protein may be an IBV-induced
host protein, it is tempting to speculate that the IBV 3C
like proteinase together with other viral products may
interact with this protein to form a multiprotein complex
involved in viral replication. The second possibility is that
the IBV 3C-like proteinase may be able to bind to viral
RNA. In poliovirus, the viral 3C proteinase was shown to
be an RNA binding protein (Andino et al., 1993). The 3C
proteinase and polymerase precursor (3CD) together
with a cellular protein can form a ribonucleoprotein com-
plex with the first 90 nucleotides of the poliovirus ge-
nome (Andino et al., 1993). This complex may play an
important role in the replication of polioviral RNA. We are
currently unclear whether the IBV 3C-like proteinase may
be involved in the formation of coronavirus replication
complexes.
MATERIALS AND METHODS
Virus and cells
The egg-adapted Beaudette strain of IBV (ATCC VR-22)
was obtained from the American Type Culture Collection
(ATCC) and was adapted to Vero cells as described
previously (Ng and Liu, 1998). The virus was passaged
three times in 11-day-old chicken embryos and then
adapted to Vero cells (ATCC CCL-81) by a series of
passages at 24- to 48-h intervals. The cytopathic effects,
including syncytium formation and rounding-up of cells,
were initially observed after three passages in Vero cells.
Virus stocks were prepared after the 62nd passage by
infecting monolayers of Vero cells at a multiplicity of
infection of approximately 0.1 PFU/cell. The virus was
harvested at 24 h postinfection and the titer of the virus
preparation was determined by plaque assay on Vero
cells.
Vero cells and Cos-7 cells were grown at 37°C in 5%
CO2 and maintained in Dulbecco’s modified minimal es-
sential medium (Gibco BRL, Life Technologies) supple-
mented with 10% newborn calf serum.
d
gRadiolabeling of IBV-infected and mock-infected Vero
cells
Confluent monolayers of Vero cells grown on 60-mm
dishes were infected with IBV at a multiplicity of infection
of approximately 2 PFU/cell. The cells were labeled for
4 h with 25 mCi/ml [35S]methionine–cysteine at 6 h
postinfection before harvesting.
Transient expression of plasmid DNAs using the
vaccinia virus-T7 expression system
Semiconfluent monolayers of Cos-7 cells grown on
60-mm dishes were infected with 10 PFU/cell of vTF7-3
(Fuerst et al., 1986) and transfected with 2.5 mg of plas-
id DNAs using 15 ml of DOTAP liposomal transfection
reagent according to the instructions of the manufacturer
(Boehringer Mannheim). After incubation of the cells at
37°C for 7 h, the cells were incubated in methionine- and
cysteine-free medium (ICN) for 30 min and labeled with
25 mCi/ml [35S]methionine–cysteine (35S Express Protein
abelling Mix, NEN Life Science) for 13 h. The cells were
craped off the dishes in phosphate-buffered saline
PBS) and recovered by centrifugation at 12,000 rpm for
min.
ell fractionation of [35S]methionine–cysteine-labeled
cells
The radiolabeled cells were resuspended in hypotonic
buffer (1 mM Tris–HCl, pH 7.4, 0.1 mM EDTA, 15 mM
NaCl) containing 2 mg/ml leupeptin and 0.4 mM phenyl-
ethylsulfonyl fluoride (PMSF) and broken by 20 strokes
ith a Dounce cell homogenizer as described (van der
eer et al., 1998). Cell debris and nuclei were removed
y centrifugation at 3500 rpm for 10 min at 4°C. The
embranes were pelleted by ultracentrifugation in a
eckman TLA 120.1 rotor (65,000 rpm for 30 min at 4°C).
embrane pellets were resuspended in immunoprecipi-
ation buffer [20 mM Tris–HCl, pH 7.4, 5 mM EDTA, 150
M NaCl, 0.5% SDS, 0.1% sodium deoxycholate, 0.5%
onidet-P40 (NP-40)] and the cytosol fraction (superna-
ant) was adjusted to the same volume and ion/detergent
onditions with 23 immunoprecipitation buffer. Samples
ere precleared by centrifugation and incubated with
nti-3C or anti-M for 30 min at room temperature, fol-
owed by 30 min incubation with protein A–Sepharose
L-4B (Sigma). Immunoprecipitated beads were washed
hree times with the immunoprecipitation buffer and an-
lyzed by SDS–PAGE.
DS–polyacrylamide gel electrophoresis
SDS–PAGE was carried out with a 12.5% polyacryl-
mide concentration, and the labeled polypeptides were
etected by autoradiography or fluorography of dried
els.
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373C-LIKE PROTEINASE OF AVIAN CORONAVIRUS IBVCell-free transcription and translation
Plasmid DNAs were expressed in rabbit reticulocyte
lysate using a transcription coupled translation system
(TnT, Promega) in the presence of [35S]methionine (Am-
ersham-Pharmacia Biotech) according to the instructions
of the manufacturer. Briefly, 1 mg of plasmid DNA was
ncubated in a 50-ml reaction mix with or without 5 ml of
anine pancreatic microsomal membranes (Promega).
liquots were either analyzed directly by SDS–PAGE or
mmunoprecipitated with polyclonal antiserum as de-
cribed previously (Liu et al., 1997).
olymerase chain reaction (PCR)
Appropriate primers and template DNAs were used in
mplification reactions with cloned Pfu DNA polymerase
Stratagene) under standard buffer conditions with 2 mM
gCl2.
ndirect immunofluorescence microscopy
Cells were grown on coverslips and infected with IBV
r transfected with appropriate plasmid DNAs. After be-
ng washed with PBS containing 1 mM CaCl2 and 1 mM
gCl2 (PBSCM), the cells were fixed with 4% paraformal-
dehyde (in PBSCM) for 30 min at room temperature and
permeabilized with 0.1% saponin (in PBSCM), followed by
incubation with specific antiserum (anti-3C) at room tem-
perature for 2 h. Antibodies were diluted in fluorescence
dilution buffer (PBSCM with 5% normal goat serum, 5%
newborn calf serum, and 2% bovine serum albumin, pH
7.6). The cells were then washed with PBSCM and incu-
bated with anti-rabbit IgG conjugated to fluorescein iso-
thiocynate (1:80, Sigma) in the fluorescence dilution
buffer at 4°C for 1 h before being mounted.
Site-directed mutagenesis
Site-directed mutagenesis was carried out by two
rounds of PCR with two pairs of primers as described
(Liu et al., 1997). The mutations introduced were verified
by automated nucleotide sequencing.
Construction of plasmids
Plasmids pIBV9 (formerly known as pKT205), pIBV3C,
pBP5D5, and pIBV1a7D1 were described previously (Liu
et al., 1994, 1997; Lim et al., 2000). The IBV sequences
resent in these constructs are nucleotides 8693 to
0,925, 8865 to 9786, 11,306 to 11,877, 6870 to 9786, and
999 to 9786, respectively.
Plasmid pIBV9D1Q2779–E, which contains the Q2779–E mu-
ation and a deletion of nucleotides 9911 to 10,925 from
IBV9, was constructed as follows. A PCR fragment cover-
ng nucleotides 8693 to 10,637 was generated by two
ounds of PCR with pIBV9 as the template. The PCR frag-ent was digested with BglII and PvuII and cloned into
glII- and SmaI-digested pKT0 (Liu et al., 1994) (see Fig. 2a).
c
QvuII cuts the IBV sequence at nucleotide position 9911 and
glII digests the PCR fragment at a position 19 nucleotides
pstream of the viral sequence. The primers used to intro-
uce the Q2779–E mutation are LN-10 (59-GTTAGTAGATTA-
AGTCTGGTTTTAAG-39) and LN-11 (59-CAGTTTCTTA-
AACCAGACTCTAATCT-39), and the primers used for the
econd round of PCR are T7 (59-TAATACGACTCACTAT-
GGG-39) and LN-8 (59-GTCACCACCAATTCCCTCTATAAG-
AT-39). Plasmid pIBV9D1Q2779–K was generated as de-
cribed for pIBV9D1Q2779–E by mutation of the Q2779 residue
to a K with primers LN-32 (59-GTTAGTAGATTAAAGTCTG-
GTTTTAAG-39) and LN-33 (59-CAGTTTCTTAAAACCAGA-
CTTTAATCTAC-39).
Plasmid pIBV9Q3086–E contains the Q3086–E mutation
nd a deletion of nucleotides 10,637 to 10,925 from
IBV9. The mutation and deletion were introduced by two
ounds of PCR with pIBV9 as the template. The PCR
ragment was digested with BglII and cloned into BglII-
nd EcoRV-digested pKT0, giving rise to pIBV9Q3086–E.
The mutation primers are LN-12 (59-GGTGTTAGATTA-
GAGTCTTCTTTTGTA-39) and LN-13 (59-AGCTTTTCTTA-
CAAAAGAAGACTCTAATCT-39), and the two primers
used for the second round of PCR are T7 and LN-8.
Plasmid pIBV9Q3086–ED1, which covers nucleotides 8693
o 9910 and contains the Q3086–E mutation, was con-
structed by religation of PvuII- and SmaI-digested
pIBV9Q3086–E, resulting in the deletion of nucleotides
9911 to 10,637. Plasmid pIBV9Q3086–ED2 was constructed
y introducing a termination codon (UAG) immediately
ownstream of the codon coding for the E3086 residue.
The primer used to introduce this mutation is LN-29
(59-AGAAGAGAGCTCTACTCTAATCTAACAC-39).
Plasmid pIBV9D17, which covers nucleotides 8693 to
9910, was constructed by religation of PvuII- and SmaI-
digested pIBV9, resulting in the deletion of nucleotides
9911 to 10,925.
Plasmids pIBV9D19, pIBV9D20, pIBV9D21, pIBV9D22,
and pIBV9D23 cover nucleotides 8693 to 9777, 8693 to
9765, 8693 to 9687, 8693 to 9585, and 8693 to 9381,
respectively, and contain a UAG termination codon im-
mediately downstream of the viral sequences. The con-
structs were made by ligation of PCR fragments covering
the appropriate regions into pKT0. The PCR fragments
were generated using pIBV9 as the template and T7 as
the upstream primer. The downstream primers are LN61
(59-TAATCTGAGCTCTAAACACCACCAATCTG-39), LN62
(59-ACCAATGAGCTCTACTGATTAAATACAGA-39), LN63
(59-CTGGCTGAGCTCTAATTTTTTACCATAAT-39), LN64
(59-ACCATTGAGCTCTAGTCACCAGCCCACTT-39), and
LN65 (59-GTCAGTGAGCTCTATCCAGTGTGTAATGC-39),
respectively.
Plasmid pIBV1a16 covers nucleotides 8693 to 11,877
and contains both Q3462–E and Q3672–E mutations. The
wo mutations were introduced into a PCR fragment
overing nucleotides 8693 to 11,877 as follows. The
3672–E mutation was incorporated into the PCR fragment
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38 NG AND LIUby using pBP5D5Q3672–E (Liu et al., 1997) as the template,
and the Q3462–E mutation was introduced by primers X-38
(59-CAACTGTATTAGAATCGGTTAC-39) and LN-2 (59-CTT-
GAGTAACCGATTCTAATACAGTTG-39). This PCR frag-
ment was cloned into pKT0, giving rise to pIBV1a16.
Plasmid pIBV1a16Q3365–E, which contains the Q3365–E
mutation (see Fig. 8a), was constructed by two rounds of
PCR with pIBV1a16 as the template. The primers used to
introduce the Q3365–E mutation were LN-7 (59-TCGA-
CAAATATACTTATAGAGGGAATTGG-39) and LN-8.
Plasmid pIBV1a16D1 covers nucleotides 8693 to
11,877 with a deletion of nucleotides 9911 to 10,634. It
was made by digestion of pIBV1a16 with BstEII (which
cuts at nucleotide 10,634), end-repair with Klenow, redi-
gestion with PvuII (cuts at nucleotide 9911), and religa-
tion with T4 DNA ligase, resulting in the deletion of
nucleotides 9911 to 10,634. pIBV1a16D2 was constructed
by deletion of nucleotides 9911 to 10,669 from pIBV1a16.
Plasmid pIBV1a16D1Q3379–E, which covers nucleotides
8693 to 11,877 with the Q3379 to E mutation, was made by
wo rounds of PCR with pIBV1a16D1 as the template. The
rimers used to introduce the Q3379 to E mutation are
LN-22 (59-CTATTGCTACAGTTGAGGCTAAATTGAGT-39)
and LN-23 (59-TACATCACTCAATTTAGCCTCAACTGTAG-
39), and the cloning primers are T7 and LDX-7 (59-GCTC-
CAGGATCCTACTGTAAGACAAC-39).
ACKNOWLEDGMENTS
We thank Ms. Haoying Xu for excellent technical assistance. This
work was supported by a grant from the National Science and Tech-
nology Board of Singapore.
REFERENCES
Andino, R., Rieckhof, G. E., Achacoso, P. L., and Baltimore, D. (1993).
Poliovirus RNA synthesis utilizes an RNP complex formed around the
59-end of viral RNA. EMBO J. 12, 3587–3598.
Baker, S. C., Shieh, C.-K., Soe, L. H., Chang, M.-F., Vannier, D. M., and
Lai, M. M. C. (1989). Identification of a domain required for autopro-
teolytic cleavage of murine coronavirus gene A polyprotein. J. Virol.
64, 3693–3699.
aker, S. C., Yokomori, K., Dong, S., Carlise, R., Gorbalenya, A. E.,
Koonin, E. V., and Lai, M. M. C. (1993). Identification of the catalytic
sites of a papain-like cysteine proteinase of murine coronavirus.
J. Virol. 67, 6056–6063.
onilla, P. J., Hughes, S. A., and Weiss, S. R. (1997). Characterization of
a second cleavage site and demonstration of activity in trans by the
papain-like proteinase of the murine coronavirus mouse hepatitis
virus strain A59. J. Virol. 71, 900–909.
oursnell, M. E. G., Brown, T. D. K., Foulds, I. J., Green, P. F., Tomely,
F. M., and Binns, M. M. (1987). Completion of the sequence of the
genome of the coronavirus avian infectious bronchitis virus. J. Gen.
Virol. 68, 57–77.
rierley, I., Boursnell, M. E. G., Binns, M. M., Bilimoria, B., Blok, V. C.,
Brown, T. D. K., and Inglis, S. C. (1987). An efficient ribosomal
frame-shifting signal in the polymerase-encoding region of the coro-
navirus IBV. EMBO J. 6, 3779–3785.
rierley, I., Digard, P., and Inglis, S. C. (1989). Characterization of an
efficient coronavirus ribosomal frameshifting signal: Requirement for
an RNA pseudoknot. Cell 57, 537–547.
Lavanagh, D. (1997). Nidovirales: A new order comprising Coronaviri-
dae and Arteriviridae. Arch. Virol. 14, 629–633.
Denison, M. R., Spaan, W. J. M., van der Meer, Y., Gibson, C. A., Sims,
A. C., Prentice, E., and Lu, X. T. (1999). The putative helicase of the
coronavirus mouse hepatitis virus is processed from the replicase
gene polyprotein and localizes in complexes that are active in viral
RNA synthesis. J. Virol. 73, 6862–6871.
e Vries, A. A. F., Horzinek, M. C., Rottier, P. J. M., and de Groot, R. J. (1997).
The genome organization of the Nidovirales: Similarities and differences
between arteri-, toro-, and coronaviruses. Semin. Virol. 8, 33–47.
ong, S. H., and Baker, S. C. (1994). Determination of the p28 cleavage
site recognized by the first papain-like cysteine proteinase of murine
coronavirus. Virology 204, 541–549.
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic
transient-expression system based on recombinant vaccinia virus
that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl.
Acad. Sci. USA 83, 8122–8127.
Gao, H. Q., Schiller, J. J., and Baker, S. C. (1996). Identification of the
polymerase polyprotein products p72 and p65 of the murine corona-
virus MHV-JHM. Virus Res. 45, 101–109.
orbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M.
(1989). Coronavirus genome: Prediction of putative functional do-
mains in the non-structural polyprotein by comparative amino acid
sequence analysis. Nucleic Acids Res. 17, 4847–4861.
rotzinger, C., Heusipp, G., Ziebuhr, J., Harms, U., Suss, J., and Siddell,
S. G. (1996). Characterization of a 105-kDa polypeptide encoded in
gene 1 of the human coronavirus HCV 229E. Virology 222, 227–235.
erold, J., Gorbalenya, A. E., Thiel, V., Schelle, B., and Siddell, S. G.
(1998). Proteolytic processing at the amino terminus of human coro-
navirus 229E gene 1-encoded polyproteins: Identification of a pa-
pain-like proteinase and its substrate. J. Virol. 72, 910–918.
eusipp, G., Grotzinger, C., Herold, J., Siddell, S. G., and Ziebuhr, J.
(1997a). Identification and subcellular localization of a 41 kDa,
polyprotein 1ab processing product in human coronavirus 229E-
infected cells. J. Gen. Virol. 78, 2789–2794.
eusipp, G., Harms, U., Siddell, S. G., and Ziebuhr, J. (1997b). Identifi-
cation of an ATPase activity associated with a 71-kilodalton polypep-
tide encoded in gene 1 of the human coronavirus 229E. J. Virol. 71,
5631–5634.
ughes, S. A., Bonilla, P. J., and Weiss, S. R. (1995). Identification of the
murine coronavirus p28 cleavage site. J. Virol. 69, 809–813.
ee, H. J., Shieh, C.-K., Gorbalenya, A. E., Koonin, E. V., la Monica, N.,
Tuler, J., Bagdzhadzhyan, A., and Lai, M. M. C. (1991). The complete
sequence (22 kilobases) of murine coronavirus gene 1 encoding the
putative proteases and RNA polymerase. Virology 180, 567–582.
im, K. P., and Liu, D. X. (1998). Characterization of the two overlapping
papain-like proteinase domains encoded in gene 1 of the coronavi-
rus infectious bronchitis virus and determination of the C-terminal
cleavage site of an 87-kDa protein. Virology 245, 303–312.
im, K. P., Ng, L. F. P., and Liu, D. X. (2000). Identification of a novel
cleavage activity of the first papain-like proteinase domain encoded
by ORF 1a of the coronavirus avian infectious bronchitis virus and
characterization of the cleavage products. J. Virol. 74, in press.
iu, D. X., Brierley, I., Tibbles, K. W., and Brown, T. D. K. (1994). A
100-kilodalton polypeptide encoded by open reading frame (ORF) 1b
of the coronavirus infectious bronchitis virus is processed by ORF 1a
products. J. Virol. 68, 5772–5780.
iu, D. X., Tibbles, K. W., Cavanagh, D., Brown, T. D. K., and Brierley, I.
(1995). Identification, expression, and processing of an 87 kDa
polypeptide encoded by ORF 1a of the coronavirus infectious bron-
chitis virus. Virology 208, 48–57.
iu, D. X., and Brown, T. D. K. (1995). Characterization and mutational
analysis of an ORF-1a-encoding proteinase domain responsible for
proteolytic processing of the infectious bronchitis virus 1a/1b
polyprotein. Virology 209, 420–427.iu, D. X., Xu, H. Y., and Brown, T. D. K. (1997). Proteolytic processing of
the coronavirus infectious bronchitis virus 1a polyprotein: Identifica-
393C-LIKE PROTEINASE OF AVIAN CORONAVIRUS IBVtion of a 10-kilodalton polypeptide and determination of its cleavage
sites. J. Virol. 71, 1814–1820.
Liu, D. X., Shen, S., Xu, H. Y., and Wang, S. F. (1998). Proteolytic mapping
of the coronavirus infectious bronchitis virus 1b polyprotein: Evi-
dence for the presence of four cleavage sites of the 3C-like protein-
ase and identification of two novel cleavage products. Virology 246,
288–297.
Louis, J. M., Clore, G. M., and Gronenborn, A. M. (1999). Autoprocessing
of HIV-1 protease is tightly coupled to protein folding. Nat. Struct.
Biol. 6, 868–875.
Lu, X. T., Lu, Y., and Denison, M. R. (1996). Intracellular and in vitro
translated 27-kDa proteins contain the 3C-like proteinase activity of
the coronavirus MHV-A59. Virology 222, 375–382.
Lu, X. T., Sims, A. C., and Denison, M. R. (1998). Mouse hepatitis virus
3C-like protease cleaves a 22-kilodalton protein from the open-
reading frame 1a polyprotein in virus-infected cells and in vitro.
J. Virol. 72, 2265–2271.
Lu, Y., Lu, X. T., and Denison, M. R. (1995). Identification and charac-
terization of a serine-like proteinase of the murine coronavirus MHV-
A59. J. Virol. 69, 3554–3559.
Netzer, W., and Hartl, F. U. (1997). Recombination of protein domains
facilitated by co-translational folding in eukaryotes. Nature 388, 343–
349.
Ng, L. F. P., and Liu, D. X. (1998). Identification of a 24-kDa polypeptide
processed from the coronavirus infectious bronchitis virus 1a
polyprotein by the 3C-like proteinase and determination of its cleav-
age sites. Virology 243, 388–395.
Nicola, A. V., Chen, W., and Helenius, A. (1999). Co-translational folding
of an alphavirus capsid protein in the cytosol of living cells. Nat. Cell
Biol. 1, 341–345.
Pinon, J. D., Mayreddy, R. R., Turner, J. D., Khan, F. S., Bonilla, P. J., and
Weiss, S. R. (1997). Efficient autoproteolytic processing of the MHV-
A59 3C-like proteinase from the flanking hydrophobic domains re-
quires membranes. Virology 230, 309–322.
Pinon, J. D., Teng, H., and Weiss, S. R. (1999). Further requirements for
cleavage by the murine coronavirus 3C-like proteinase: Identification
of a cleavage site within ORF1b. Virology 263, 471–484.Schiller, J. J., Kanjanahaluethai, A., and Baker, S. C. (1998). Processing
of the coronavirus MHV-JHM polymerase polyprotein: Identification
of precursors and proteolytic products spanning 400 kilodaltons of
ORF1a. Virology 242, 288–302.
Seybert, A., Ziebuhr, J., and Siddell, S. G. (1997). Expression and char-
acterization of a recombinant murine coronavirus 3C-like proteinase.
J. Gen. Virol. 78, 71–75.
Shi, S. T., Schiller, J. J., Kanjanahaluethai, A., Baker, S. C., Oh, J.-W., and
Lai, M. M. C. (1999). Colocalization and membrane association of
murine hepatitis virus gene 1 products and de novo-synthesized viral
RNA in infected cells. J. Virol. 73, 5957–5969.
Tibbles, K. W., Brierley, I., Cavanagh, D., and Brown, T. D. K. (1996).
Characterization in vitro of an autocatalytic processing activity asso-
ciated with the predicted 3C-like proteinase domain of the corona-
virus avian infectious bronchitis virus. J. Virol. 70, 1923–1930.
Tibbles, K. W., Cavanagh, D., and Brown, T. D. K. (1999). Activity of a
purified His-tagged 3C-like proteinase from the coronavirus infec-
tious bronchitis virus. Virus Res. 60, 137–145.
van der Meer, Y., van Tol, H., Locker, J. K., and Snijder, E. J. (1998).
ORF1a-encoded replicase subunits are involved in the membrane
association of the arterivirus replication complex. J. Virol. 72, 6689–
6698.
van der Meer, Y., Snijder, E. J., Dobbe, J. C., Schleich, S., Denison, M. R.,
Spaan, W. J. M., and Locker, J. K. (1999). Localization of mouse
hepatitis virus nonstructural proteins and RNA synthesis indicates a
role for late endosomes in viral replication. J. Virol. 73, 7641–7657.
Ziebuhr, J., Herold, J., and Siddell, S. G. (1995). Characterization of a
human coronavirus (strain 229E) 3C-like proteinase activity. J. Virol.
69, 4331–4338.
Ziebuhr, J., Heusipp, G., and Siddell, S. G. (1997). Biosynthesis, purifi-
cation, and characterization of the human coronavirus 229E 3C-like
proteinase. J. Virol. 71, 3992–3997.
Ziebuhr, J., and Siddell, S. G. (1999). Processing of the human corona-
virus 229E replicase polyproteins by the virus-encoded 3C-like pro-
teinase: Identification of proteolytic products and cleavage sites
common to pp1a and pp1ab. J. Virol. 73, 177–185.
